Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Eli Lilly and Company Clinical Trials Information presented on Clinical Trials Search is not meant to be a substitute for proven medical advice, calls or professional assistance using a real physician. We are not doctors. Always consult your mD on Eli Lilly and Company clinical studies. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Eli Lilly and Company Clinical research trials and Eli Lilly and Company healthcare trials happen in many of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectualness of new drugs. The propose of the studies / projects is to solve certain human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector companies like Eli Lilly and Company to detect remedies for all sorts of conditions. Eli Lilly and Company Clinical Trials and other clinical trials permit volunteers to get medical treatment alternatives before they are available to the masses. Most times the subjects undergo professional assistance for free, and every now and again they are paid for their time. Occasionally there is a cost for a Eli Lilly and Company clinical trial. Participants typically recieve the finest healthcare available for their condition. Risks are a reality, nevertheless, and may include additional or frequent mD calls, health risks (perhaps life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Sponsors > Eli Lilly and Company Clinical Trials

Eli Lilly and Company Clinical Trials



A Phase 1 Trial of ALIMTA (pemetrexed) in Patients With Locally Advanced or Metastatic Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A phase 2 trial of ALIMTA (LY231514, pemetrexed) plus oxaliplatin administered every 21 days for first-line treatment of patients with advanced colorectal cancer.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase 2 Trial of ALIMTA (pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase 2 Trial of ALIMTA (pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional cell Carcinoma of the Urothelium
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase 2 Trial of Antisense Nucleotide to PKC-alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients with Advanced, Previously Untreated Non-Small Cell Lung Cancer.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase 3 Trial of ALIMTA (LY231514, pemetrexed) plus GEMZAR Versus GEMZAR in Patients with Unresectable or Metastatic Cancer of the Pancreas.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin versus Gemcitabine and Cisplatin in Patients with Advanced, Previously Untreated Non-Small Cell Lung Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients with Metastatic Breast Cancer.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients with Severe Sepsis
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Safety Evaluation of Xigris in Patients with Blood Cancer who Develop Severe Infection related to Bone Marrow Transplantation.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Study of ALIMTA (pemetrexed) Plus Carboplatin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Study of IC351 (tadalafil) for the treatment of diabetic patients with symptoms of dyspepsia (upset stomach) and gastroparesis (delayed gastric emptying).
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A study with Gemzar and LY293111 in patients with pancreatic cancer.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A study with Gemzar, Cisplatin, and LY293111 in non-small cell lung cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Trial of ALIMTA (pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

A Trial of CS-747 Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

ALIMTA (pemetrexed) and Gemcitabine (gemzar) in Patients with Advanced Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Alimta (pemetrexed) in Patients with Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have not had Previous Chemotherapy.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

ALIMTA plus Carboplatin as Front-Line Chemotherapy for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

An evaluation of an oral antidiabetic agent for the treatment of type 2 diabetes
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

An Investigational Drug Compared to a Marketed Drug and Placebo in the Treatment of Patients with Depression
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Combined Use of Study Drug and a marketed SERM (Selective Estrogen Receptor Modulator) in Postmenopausal Women with Osteoporosis
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Comparison of Study Drug With Alendronate on How it Effects Glucocorticoid-Induced Osteoporosis
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Duloxetine vs. active comparator for the treatment of depression
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Duloxetine vs. active comparator in the treatment of patients with depression
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Efficacy and Safety of LY451395 in Patients with Probable Alzheimer's Disease
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Gemzar (gemcitabine) and Alimta (pemetrexed) in the Treatment of Patients with Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Hormone Therapy With LY353381 Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Investigational compound versus Placebo in the Treatment of Painful Diabetic Neuropathy
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

LY333531 Treatment for Symptomatic Peripheral Neuropathy in Patients with Diabetes.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

New oral anticoagulant therapy for the prevention of blood clots following hip or knee replacement surgery
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Olanzapine Versus Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Open-Label Treatment with Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients with Major Depression
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Phase 3 study of LY353381 vs tamoxifen in women with locally advanced or metastatic breast cancer.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Prophylactic Heparin during Xigris [Drotrecogin Alfa (Activated)] Treatment of High-Risk Severe Sepsis
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Study of Duloxetine in Elderly Patients with Major Depressive Disorder
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

Study of two doses of ALIMTA (pemetrexed) as first line chemotherapy for advanced breast cancer
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

The Assessment of a weight-gain agent for the Treatment of Olanzapine-Associated Anti-obesity Agent in Patients with Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company

The effect of LY333531 on protein in the urine in patients with type 2 diabetes.
Condition: eli_lilly_and_company_clinical_trials.html
Eli Lilly and Company



Eli Lilly and Company Clinical Trials
Modify your Search

Other "E" Clinical Trials Sponsors:

Earle A. Chiles Research Institute
Eastern Cooperative Oncology Group
Ebmt Solid Tumors Working Party
Edap Technomed
Edelman, Martin, M.d.
Eisai Medical Research Inc
Elan Pharmaceuticals
Eleos, Inc.
Eli Lilly And Company
Emd Pharmaceuticals
Emory University
Encysive Pharmaceuticals
Endovasc
Enzon
Eortc Biological Therapeutics Development Study Group
Eortc Boron Neutron Capture Therapy Study Group
Eortc Brain Tumor Cooperative Group
Eortc Breast Cancer Cooperative Group
Eortc Children's Leukemia Cooperative Group
Eortc Chronotherapy Study Group
Eortc Cutaneous Lymphoma Task Force
Eortc Early Clinical Studies Group
Eortc Gastrointestinal Tract Cancer Cooperative Group
Eortc Genito-Urinary Tract Cancer Cooperative Group
Eortc Gynecological Cancer Cooperative Group
Eortc Head And Neck Cancer Cooperative Group
Eortc International Antimicrobial Therapy Group
Eortc Invasive Fungal Infections Cooperative Group
Eortc Leukemia Cooperative Group
Eortc Lung Cancer Cooperative Group
Eortc Lymphoma Cooperative Group
Eortc Melanoma Cooperative Group
Eortc New Drug Development Group
Eortc Quality Of Life Study Group
Eortc Radiotherapy Cooperative Group
Eortc Soft Tissue And Bone Sarcoma Cooperative Group
Epimmune
Eunoe
European Ewing Tumour Working Initiative Of National Groups
European Infant Neuroblastoma Study Group - 1999
European Institute Of Oncology
European Organization For Research And Treatment Of Cancer
European Osteosarcoma Intergroup
Eximias Pharmaceutical
Eyetech Pharmaceuticals


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103